Company Study of Huadong Medicine
  • May/2008
  • Hard Copy
  • USD $599
  • Pages:33
  • Single User License
    (PDF Unprintable)       
  • USD $599
  • Code:
  • Enterprise-wide License
    (PDF Printable & Editable)       
  • USD $1,200
  • Hard Copy + Single User License
  • USD $649

Huadong Medicine Co., Ltd. was founded in March, 1993, based on the medicine distribution network in Hanzhou, capital of Zhejiang province, after a government-oriented restructuring. On December 22, 1999, the company went public on the Shenzhen Stock Exchange and raised around CNY288 million through issuing 5,000 shares. Its main business covers the production and sale of chemical medicine and traditional Chinese medicine.

Structure of Main Business Revenue of Huadong Medicine

(Unit: CNY billion)
Source: ResearchInChina

Huadong Medicine's main business revenue covers two parts-pharmacy industry and pharmacy business. Since the gross profit margin of pharmacy industry is much higher than the pharmacy business, Huadong Medicine has been making vigorous efforts to open up the market of the pharmacy industry, which has made the proportion of its pharmacy industry to the total main business revenue increase year by year. This is one of the key reasons that the company's performance rose gradually in the recently years.

According to the company's announcement on April 3, 2008, Huadong Medicine plans to acquire 78.87% stake in Xi'an Bohua Pharmaceutical Co., Ltd. and 65% stake in the latter's subsidiary named Shaanxi Jiuzhou Medicine Co., Ltd. for CNY98 million. The acquisition, if done, will not only help the company reinforce its strength in special pharmaceutical raw materials, but also enter the narcotic market with high barriers to enter.


1. Huadong Medicine Company Profile
1.1 Brief Introduction
1.2 Shareholders of Huadong Medicine
1.3 Pharmacy Policies
1.3.1 Hospital to Follow the Measures for Prescription Management
1.3.2 Industry Concentration to Be Lifted Greatly by Improved Environment Protection Standards

2. Main Business of Huadong Medicine 
2.1 Products
2.2 Pharmacy Industry
2.2.1 Immunosuppressant Products
2.2.2 Diabetes Medicines
2.2.3 Anti-peptic ulcer medicine
2.2.4 Pharmaceutical Raw Material
2.2.5 Summery on Pharmacy Industry 
2.3 Pharmacy Business 
2.4 Marketing and Development Strategies
2.4.1 Marketing Strategy
2.4.2 Development Strategy

3. Financial Status of Huadong Medicine Co., LTD
3.1 Solvency 
3.2 Operation Efficiency
3.3 Profitability
3.4 Growing Ability
3.5 Financial Structure
3.6 Cash Flow Ratio

4. SWOT Analysis
4.1 Strength 
4.2 Weakness
4.3 Opportunities 
4.4 Threats

5. Summarization 

Huadong Medicine's Shareholding Structure 
Huadong Medicine's Organization Structure 
Huadong Medicine's Top Ten Shareholders As of 2007
Huadong Medicine's Main Products
Huadong Medicine's Main Businesses, 2003-2007
Huadong Medicine's Business Structure in 2007
Huadong Medicine's Gross Profit Margin, 2003-2007
Companies Producing Main Products of Huadong Medicine
Huadong Medicine's Sales Revenue by Product, 2007
Huadong Medicine's Sales Revenue of Main Products 
Huadong Medicine's Pharmacy Industry Performance, 1998-2007
Huadong Medicine's Distribution Targets in 2006 
Development Thought of the Western Medicine Sector
Huadong Medicine's Sales Revenue and Growth by Product, 2004-2008
Distribution of China Immunosuppressant Market Share
Purchasing Value of Sampled Immunosuppressant in Typical Cities of China
Growth Rate of Sampled Immunosuppressant in Typical Cities of China
Four Families in Cyclosporine Market
Immunosuppressant Markets in the U.S. and China
China Diabetes Market Scale and Its Growth, 2002-2006
Market Shares of Sampled Diabetes Medicines, 2005-2006
Market Shares of Pioglitazone Producers in 16 Chinese Sampled Cities
Top Ten Diabetes Medicine Producers in China, 2004-2006
Huadong Medicine's Revenue, Growth Rate and Profit Margin from Diabetes and Peptic Medicine, 2004-2008
Main Peptic Ulcer Drugs Applied in Clinic in China and their Market Shares
Proton Pump Inhibitor Main Products and Market Shares, 2004-2006
Pantoprazole Market Share and Growth, 2004-2006
Competition among Pantoprazole Producers
Competition among Omeprazole Producers
Huadong Medicine's Sales Revenue and Growth Rate, 2004-2008
Huadong Medicine's Specific Quality Standards for Bulk Raw Material Purchasing 
Growth of Huadong Medicine's Business 1998-2007
Huadong Medicine's Distribution Network
Huadong Medicine's Production, Sales, and Technical Team, 2006-2007
Products of General Agents above Designated Scale, 2005-2007
Ornidazole Applied for Gynecological Inflammation Disease, 2004-2006
Market Shares of Ornidazole
Huadong Medicine's Solvency
Huadong Medicine's Operation Efficiency 
Huadong Medicine's Profitability
Huadong Medicine's Growing Ability
Huadong Medicine's Financial Structure
Huadong Medicine's Cash Flows

China Interventional Cardiovascular Device Industry Report,2014-2017

The prevalence of cardiovascular disease in China impacted by accelerated aging of population and changes in consumption concept, dietary habit, way of working and other lifestyles has been growing ye...

China PTCA Balloon Market Investment Report, 2014-2016

PTCA balloon, as a indispensable medical device in percutaneous coronary intervention (PCI), serves not only as a delivery system for stent, but also as a device for pre-/post-stent dilatations. There...

China Orthopedic Instrument Industry Report, 2014-2017

Benefiting from accelerated aging population and rising proportion of reimbursement for medical expenses, the Chinese orthopedic instrument market demand has been effectively released, with its scale ...

China Hospital Development and Investment Report, 2014-2017

China hospital industry has been developing quickly in recent years, thanks to the market demand stimulus and steady progress in health care reform. The number of Chinese hospitals grew at a CAGR of 6...

China Diagnostic Reagent Industry Report, 2013-2016

With the accelerated aging of the Chinese population, the increase of personal health expenditure as well as the improved medical care facilities and government health care system, China diagnostic re...

China Hemodialysis Equipment Import and Export Report, 2013-2016

Hemodialysis equipment is the most widely used treatment apparatus in blood purification, primarily targeting patients with acute or chronic renal failure.The Chinese hemodialysis equipment market sho...

Global and China Hemodialysis Industry Report, 2013-2016

Hemodialysis, also known as artificial kidney, is a type of blood purification technology, primarily applicable to the treatment of patients with rental failure. In 2013, the global number of patient...

China Portable Medical Equipment Industry Report, 2013-2016

With the synergy of favorable policies, improvement in living standards and healthcare awareness raising, China’s portable medical device industry has shown rapid development in recent years, with mar...

China Medical Informatization Industry Report,2013-2016

Under the impetus of multiple favorable policies and market demand, China's medical informatization industry has entered a rapid development stage in recent years. As of the first half of 2013, manage...

China Aged Care Industry Report, 2013-2016

Currently, China has entered the accelerated aging period. China’s population aged 65 and above reached 131.61 million in 2013, accounting for 9.7% of total population; and the proportion will rise to...

China Pharmaceutical Equipment Industry Report, 2013-2016

After decades of development, China has become a major producer of pharmaceutical equipment in the world. Since 2010, affected by the new GMP certification and other factors, the revenue and total pro...

China Dental Industry Report, 2013-2016

The dental industry refers to medical industrial chain on the basis of oral medical consumption, consisting mainly of dental appliances (equipments and consumables), dental medical services, etc. with...

China Medical Monitor Industry Report, 2013-2015

In 2007-2011, the Chinese medical monitor market size rose from RMB1.16 billion to RMB3.08 billion at a CAGR of 27.8%. In 2012, the figure reached RMB3.86 billion, a year-on-year increase of 25.3%, of...

China Interventional Cardiovascular Device Industry Report, 2013-2015

With the accelerated aging, the prevalence of cardiovascular diseases in China increased year by year. According to statistics of National Health and Family Planning Commission of the People’s Republi...

China Diagnostic Reagent Industry Report, 2013-2015

Driven by huge population base, intensified aging and many favorable policies, China diagnostic reagent industry has been developing rapidly. In 2008-2012, the diagnostic reagent market size presented...

China Orthopedic Instrument Industry Report, 2013-2015

Benefiting from aging of population, consumption upgrade and policy support, China's orthopedic instrument industry has seen rapid development over the years, with total market size rising from 3.28 b...

China Ophthalmic Hospital Industry Report, 2012-2015

With the growing types of eye diseases and non-basic medical needs, China’s ophthalmic hospital industry has seen rapid development. In 2011, the number of ophthalmic hospitals in China reached 288, w...

China Chinese Patent Medicine Industry Report, 2012-2015

In recent years, China’s Chinese patent medicine industry has been running in good condition, with the revenue increasing from RMB 142 billion in 2008 to RMB 360 billion in 2012 at a CAGR of 26.2%. Ov...

2005-2014 All Rights Reserved 京ICP备05069564号-1 京公网安备1101054484号